AUTL Insider Trading Activity and SEC Form 4 Filings
AUTL insider trading summary
Over the past 12 months, insiders at Autolus Therapeutics plc (AUTL) reported 1 sale worth $16K by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $16K.
Latest AUTL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Cintia Piccina | U.S. CCO & Country Gen Manager | Sell | $16K (6,713 @ $2.34) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.